Beta blocker metoprolol protects against contractile dysfunction in rats after coronary microembolization by regulating expression of myocardial inflammatory cytokines

Life Sciences

Volumn 88, Issue 23-24, 2011, Pages 1009-1015

  Lu, Yongguang ^a   Li, Lang ^a   Zhao, Xianming ^a   Huang, Weiqiang ^a   Wen, Weiming ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Coronary microembolization; Cytokine; Metoprolol; Myocardial function

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; METOPROLOL; MICROSPHERE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY MICROEMBOLIZATION; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION; HEART PROTECTION; HEART VENTRICLE FUNCTION; MALE; MICROEMBOLISM; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; EMBOLISM; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; METOPROLOL; MICROSPHERES; MYOCARDIAL CONTRACTION; POLYETHYLENE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

RATTUS;

EID: 79957558144     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.03.012     Document Type: Article

References (28)

1. Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, et al. Cytokines network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:376-82. (Pubitemid 29066497)
2. Bozkurt B, Kribbs SB, Clubb Jr FJ, Michael LH, Didenko VV, Hornsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382-91. (Pubitemid 28182677)
3. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1622-32.
4. D'Orazio TJ, Niederkorn JY. A novel role of TGF-B and IL-10 in the induction of immune privilege. J Immunol 1998;160:2089-98. (Pubitemid 28119886)
5. Damas JK, Aukrust P, Ueland T, Odegaard A, Eiken HG, Gullestad L, et al. Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes. Basic Res Cardiol 2001;96: 345-52. (Pubitemid 32700571)
6. Dörge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, et al. Perfusion- contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000;279:H2587-92.
7. Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, et al. Coronary microembolization: the role of TNF-α in contractile dysfunction. J Mol Cell Cardiol 2002;34:51-62. (Pubitemid 34146395)
8. Kalenikova EI, Gorodetskaya EA, Zacharova NV, Shechter AB, Medvedev OS. Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats. J Cardiovasc Pharmacol 1998;32:608-15. (Pubitemid 28440962)
9. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997;81:187-95. (Pubitemid 27342485)
10. Kato H, Kawaguchi M, Inoue S, Hirai K, Furuya H. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats. Anesth Analg 2009;108(1):288-95.
11. Lie JT, Holley KE, Kampa WR, Titus JL. New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc 1971;46:319-27.
12. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995;91:2642-54.
13. McTiernan CF, Lemster BH, Frye C, Brooks S, Combes A, Feldman AM. Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res 1997;81:493-503. (Pubitemid 27432736)
14. Miura M, Thomas R, Ganz W, Sokol T, Shell WE, Toshimitsu T, et al. The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation 1979;59:1148-57. (Pubitemid 9178551)
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765. (Pubitemid 32368050)
16. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic noreflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-9.
17. Ng MK, Celermajer DS. Glucocorticoid treatment and cardiovascular disease. Heart 2004;90:829-30. (Pubitemid 39005918)
18. Nishii M, Inomata T, Niwano H, Takehana H, Takeuchi I, Nakano H, et al. Beta2- adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2- adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 2006;114:936-44. (Pubitemid 44337137)
19. Oyama J, Shimokawa H, Momii H, Cheng X, Fukuyama N, Arai Y, et al. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Investig 1998;101:2207-14. (Pubitemid 28244104)
20. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-53. (Pubitemid 39648205)
21. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. β-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101:2103-9. (Pubitemid 30233176)
22. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumor necrosis factor-alpha. Br J Pharmacol 1995;114:27-34.
23. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, et al. Elevated levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997;17:145-50. (Pubitemid 27148704)
24. Skyschally A, Haude M, Dörge H, Thielmann M, Duschin A, van de Sand A, et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004;109:2337-42. (Pubitemid 38678523)
25. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140-6. (Pubitemid 46066782)
26. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104:746-9. (Pubitemid 32762668)
27. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 2002;90:807-13. (Pubitemid 34633897)
28. Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary β-blocker. Circulation 2003;107:2914-9. (Pubitemid 36736632)